What payment terms are accepted?

We accept T/T, L/C, D/P, PayPal, Western Union, Money Gram, and small-amount payments.

High-Potency Ciprofloxacin 500mg Tablets for Effective Infection Treatment

Name: High-Potency Ciprofloxacin 500mg Tablets for Effective Infection Treatment
Brand: Jiangxi Serum Pharma Industries Co., Ltd.
SKU: 2121197675

Jiangxi, ChinaJiangxi Serum Pharma Industries Co., Ltd.

US$20.00-999.00

10,000 boxes

Sample price:US$80.00/piece.Request sample

Product profile

Customization

Available

Powder

Customized

Model NO.

ANTI-12-07

Certification

GMP, Copp

Suitable for

Adult

State

Solid

Purity

>99%

Transport Package

Level 3

Specification

500mg, 10’ sX10/Box

Trademark

Serumpharm

Origin

China

HS Code

2901231000

Key features

High Potency Formula: 500mg Ciprofloxacin tablets with purity greater than 99% for effective infection treatment.

OEM/ODM Support: Customized manufacturing services available for branded and generic pharmaceutical products.

International Certifications: Products accredited with GMP, COPP, ISO9001, CP, and BP standards for quality assurance.

Global Market Reach: Exported to over 30 countries across Asia, Africa, South America, Middle East, and Europe.

Experienced Supplier: Over 10 years of experience in exporting biological products, vaccines, and pharmaceutical APIs.

Strict Quality Control: Full process control from raw material procurement to shipment under China GMP requirements.

Competitive Pricing: Top quality pharmaceutical products offered at reasonable prices with reliable supply.

Flexible Payment Terms: Accepts T/T, L/C, D/P, PayPal, Western Union, and Money Gram for various order sizes.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceExperienced Team

Jiangxi Serum Pharma Industries Co., Ltd.

Jiangxi, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2024-04-17Nearest Port: SHANGHAIAverage Response Time: ≤6.90hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, CFR

AI-Powered supplier vetting

SummaryJiangxi Serum Pharma Industries Co., Ltd. is a limited company offering human medicines, medical consumables, medical devices, disinfectants, and veterinary medicines. It holds ISO 13485, ISO 9001, and GMP certifications, has documented service, corrective-action, and complaint-handling procedures, and reports valid import/export licensing with 90% of sales from exports. The supplier provides broad customization, ODM, and OEM services, and has cooperated with domestic biological-product, vaccine, API, and auxiliary-material manufacturers. However, no new products were reported in the past year, no SDK is available, raw-material traceability status is unknown, and sustainability-related compliance statuses are also unknown. Production scale and organizational information are limited and should be verified further.

Supplier typeThe supplier is identified as a limited company with no larger-company affiliation. Its stated product scope covers human medicine, medical consumables, medical devices, disinfectants, and veterinary medicine, indicating a diversified pharmaceutical and healthcare supplier profile.

CertificationsThe supplier reports holding ISO 13485, ISO 9001, and GMP certifications. These certifications directly support quality-management and pharmaceutical/medical-product compliance, although the provided slices do not show certificate validity dates or scope details.

After-Sales capabilityThe supplier states that it provides after-sales service, while its service-capability assessment, corrective and preventive action, and customer-complaint processes are documented and supported by followed records. This provides explicit evidence of a structured service and complaint-management system.

Customization capabilityThe supplier explicitly supports customization from samples, designs, full customization, minor customization, and flexible customization. Its ODM and OEM capabilities further support tailored product development and manufacturing.

Client casesThe supplier reports close cooperation with domestic manufacturers of biological products, vaccines, APIs, and auxiliary materials, provides OEM services for well-known brands, has participated in the CPHI offline trade show, and has exported for seven years with 90% of sales from exports. These are relevant experience indicators, but no named customers, project details, or independently verifiable case outcomes are provided.